Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
2020 · New England Journal of Medicine · 6,783 citations
https://doi.org/10.1056/nejmoa1915745
C
Chen Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
8.5K
Citations
19
h-index
26
i10-index
Chen Huang is an academic researcher from Sichuan University. The author has contributed to research in topics: Cancer Mechanisms and Therapy & Hepatocellular Carcinoma Treatment and Prognosis & Colorectal Cancer Treatments and Studies. The author has an h-index of 19, co-authored 43 publications.
ORCID: 0000-0001-8535-6417Papers by this author
worksWhat role does pyroptosis play in cancer?
2022 · Molecular Metabolism · 33 citations
https://doi.org/10.1016/j.molmet.2022.101587
Targeting pyroptosis for cancer immunotherapy: mechanistic insights and clinical perspectives
2025 · Molecular Cancer · 29 citations
https://doi.org/10.1186/s12943-025-02344-4
Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition
2022 · Cell Death and Disease · 27 citations
https://doi.org/10.1038/s41419-022-05061-8
Inhibition of SQSTM1 S403 phosphorylation facilitates the aggresome formation of ubiquitinated proteins during proteasome dysfunction
2023 · Cellular & Molecular Biology Letters · 7 citations
https://doi.org/10.1186/s11658-023-00500-6
Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma
2025 · Cell Biology and Toxicology · 3 citations
https://doi.org/10.1007/s10565-024-09979-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat